Glycoconjugate vaccines (LimmaTech Biologics)

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameGlycoconjugate vaccines (LimmaTech Biologics)

Drug Alias NameGroup B meningococcal vaccine - GlycoVaxynStaphylococcus aureus vaccine - GlycoVaxynUropathogenic E.Coli vaccine - GlycoVaxynGlycoconjugate vaccines - GlycoVaxynGroup A Streptococcus conjugate vaccine - GlycoVaxyn

ClassificationVaccines > Application > Therapeutic vaccine

Mechanisms of ActionImmunostimulants

TargetsNot applicable

Therapy Area/IndicationsStaphylococcal InfectionsBacterial Infections

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesGlycovaxyn Ag Limmatech Biologics Ag

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesGlycovaxyn Ag Limmatech Biologics Ag

Active IndicationsN/A

Inactive IndicationsStaphylococcal InfectionsBacterial Infections

Other Information

ATC CodeN/A